Skip to content
Psych Dictionary

Metacognitive therapy

(MCT)

  • Therapy · Third-wave cognitive-behavioral
  • Moderate evidence
  • Published October 19, 2026
  • 13 sources
  • 6 min read

In short

Metacognitive therapy (MCT) is a psychological treatment developed by Adrian Wells that targets how people respond to their thoughts rather than what the thoughts say. It aims to reduce worry, rumination and threat monitoring and to change the beliefs about thinking that sustain them.

Key facts

Tradition
Third-wave cognitive-behavioral
Developed by
Adrian Wells, University of Manchester, from the self-regulatory executive function model developed with Matthews
Origin
Attention training technique described in 1990; S-REF model set out in 1994; treatment manual published in 2009
Typical format
Individual or group sessions; trials have used up to 14 sessions for generalized anxiety disorder, 12 weekly sessions for obsessive-compulsive disorder and up to 24 sessions for depression
Most researched for
Generalized anxiety disorder; Major depressive disorder; Obsessive-compulsive disorder
Also known as
Wells’s metacognitive therapy

State of the evidence

Moderate evidence

Randomized trials in generalized anxiety disorder found metacognitive therapy more effective than intolerance-of-uncertainty therapy and cognitive behavioral therapy[1][2]. In depression, one trial favored it over cognitive behavioral therapy on self-report but not on a clinician-rated scale[3], and another found no difference from behavioral activation[4]. Meta-analyses report large effects against waiting lists and smaller advantages over cognitive and behavioral treatments[5][6]. Samples are small, and the therapy’s developer is an author of several of the trials.

Evidence labels summarise the research literature; they are not recommendations. How labels are assigned

Metacognitive therapy (MCT) is a psychological treatment, developed by Adrian Wells, that targets the way a person responds to thoughts rather than what the thoughts say. Its basis is the self-regulatory executive function (S-REF) model, which holds that most psychological disorders are maintained by a perseverative style of thinking, the cognitive attentional syndrome, and by the knowledge about thinking that drives it[7]. In treatment the validity of beliefs about thinking is questioned, but the validity of ordinary negative thoughts is not[7]. The wider concept, and other interventions that share the word, are covered under metacognition.

The self-regulatory executive function model

Wells and Matthews set out the S-REF model in Attention and Emotion: A Clinical Perspective, first published in 1994. Rooted in cognitive psychology, it was meant to account for laboratory findings on attention bias, individual differences in stress responses and the causes of disorder, and Wells calls it a major influence on the development of the therapy[7].

The model separates two kinds of metacognitive knowledge. Declarative knowledge can be put into words as beliefs about thinking, such as “worrying is harmful.” Procedural knowledge exists as implicit plans that instruct the cognitive system how to operate, including the instructions that generate worry or rumination[7]. In 2019 Wells extended the model with a proposed metacognitive control system, distinct from the cognitive system, that monitors and controls cognitive activity. On this account, therapy has to reach and rewrite the procedural plans as well as the stated beliefs[7].

The cognitive attentional syndrome

The cognitive attentional syndrome (CAS) is a state in which negative information about the self is given priority and processing becomes extended and repetitive. Its main forms are worry about how to deal with future threats and rumination aimed at understanding past events and feelings. Threat monitoring adds strategies such as checking for symptoms or thoughts and scanning the environment for signs of danger, for example contamination or rejection. Avoidance, inactivity, thought suppression and substance use complete the pattern[7]. On this account the strategies prolong negative processing and deprive the person of the experience of it stopping by itself[7].

His illustration is a depressed patient who, feeling lethargic, thought “I don’t have the strength to cope,” then analyzed why he lacked energy, compared himself with others, repeatedly asked why he felt depressed, monitored his fatigue, criticized himself and reduced his activity to conserve strength. In the model, these responses rather than the first thought prolong the depression[7]. The syndrome is driven by dysfunctional metacognitive beliefs, for example about the need to worry or the danger of thoughts[8].

How the cognitive attentional syndrome is maintained in metacognitive therapyA theoretical account. At the top, side by side: a first negative thought, for example I don’t have the strength to cope; and metacognitive beliefs, declarative, such as worrying is harmful, and procedural plans that generate worry or rumination. The thought leads to, and the beliefs drive, the cognitive attentional syndrome: worry, rumination and threat monitoring, with avoidance, inactivity, thought suppression and substance use. The syndrome leads to its consequence: negative processing is prolonged, and the person is deprived of the experience of it stopping by itself. A note says that, in the model, these responses rather than the first thought prolong the depression.A THEORETICAL ACCOUNTA first negativethoughtFor example, “I don’thave the strength tocope”MetacognitivebeliefsDeclarative, such as“worrying is harmful”,and procedural plansthat generate worry orruminationCognitive attentional syndromeWorry, rumination and threat monitoring, withavoidance, inactivity, thought suppression andsubstance useNegative processing is prolongedThe person is deprived of the experience of itstopping by itselfdriveprolongsIn the model, these responses rather than thefirst thought prolong the depression.

Figure 1A theoretical account from metacognitive therapy: metacognitive beliefs drive the cognitive attentional syndrome, and when a first negative thought is met with worry, rumination and threat monitoring, those responses prolong negative processing. After Wells (2019) and Myers and colleagues (2026).

Text description

A theoretical account. At the top, side by side: a first negative thought, for example I don’t have the strength to cope; and metacognitive beliefs, declarative, such as worrying is harmful, and procedural plans that generate worry or rumination. The thought leads to, and the beliefs drive, the cognitive attentional syndrome: worry, rumination and threat monitoring, with avoidance, inactivity, thought suppression and substance use. The syndrome leads to its consequence: negative processing is prolonged, and the person is deprived of the experience of it stopping by itself. A note says that, in the model, these responses rather than the first thought prolong the depression.

Metacognitive mode and treatment targets

In what the model calls object mode, thoughts are treated as direct perceptions of fact. In metacognitive mode, they are experienced as events in the mind that the person can step outside[7]. Treatment techniques are designed to induce and hold this mode during sessions. Wells lists meta-level discourse, the attention training technique, the free-association and tiger tasks, rumination postponement, metacognitive focused exposure, metacognitive experiments and worry-modulation procedures, which are described in detail in his treatment manual[7][9].

Wells illustrates the difference from cognitive therapy with low self-esteem: a cognitive therapist asks for the evidence that the patient is a failure; a metacognitive therapist asks “What’s the point in analyzing your failures?” and then uses techniques that let the patient step back from the perseverative thinking[7]. The exception is a negative belief about thinking itself, such as “Worrying will cause cancer,” which is evaluated and replaced[7].

Attention training technique

The attention training technique (ATT), described by Wells in 1990, is a 15-minute auditory exercise with three components: selective attention, attention switching and divided attention. It was designed to increase attentional flexibility and to reduce perseverative conceptual activity[8], and it targets self-focused processing[10].

A systematic review co-authored by Wells found 10 studies with 295 participants. Pooled single-case effect sizes ranged from 0.74 to 1.00 for anxiety and depressive disorders, and four analogue randomized trials gave adjusted effect sizes from 0.40 to 1.23 in favor of the technique. The authors described the results as preliminary because the studies were few and small[10].

Detached mindfulness

Detached mindfulness is a central technique of the therapy and is used across disorders. The person notices an intrusive thought, takes a decentered stance toward it, refrains from analyzing it and leaves it to occupy its own mental space without responding[8]. Six elements are specified: meta-awareness of thoughts as mental events, cognitive decentering, flexible attention, low conceptual processing, low goal-directed coping, which means no attempt to suppress or neutralize the intrusion, and an awareness of the self as an observer of mental events[8].

Despite the name, it differs from many interventions based on mindfulness. It does not involve heightened awareness of sensory experience or the present moment, attentional anchoring, meditation or breathing exercises[8]. Exercises include the tiger task, in which the person imagines a tiger and watches it without intervening, a free-association task in which the person only listens to a list of neutral and then triggering words, and an experiment contrasting detached mindfulness with thought suppression[8].

A 2026 meta-analysis found 14 studies with 256 participants. In three clinical trials of detached mindfulness alone, two in obsessive-compulsive disorder and one in panic disorder, symptoms fell substantially (pooled g = −1.80). The authors called the evidence converging but limited, citing few studies, methodological shortcomings and little long-term follow-up[8].

Trials in generalized anxiety disorder

In a Dutch trial, 126 outpatients were randomly allocated to metacognitive therapy, intolerance-of-uncertainty therapy or delayed treatment, with up to 14 sessions. Afterward 91% of the metacognitive therapy group and 80% of the comparison group no longer met criteria, and metacognitive therapy did better on most measures[1]. Wells was not among the authors.

A Norwegian trial assessed 246 patients with long-term generalized anxiety disorder and randomized 81 to cognitive behavioral therapy, metacognitive therapy or a waiting list. Recovery rates were 65% with metacognitive therapy and 38% with cognitive behavioral therapy, and the difference held at two years. According to the declarations of interest, Wells wrote the metacognitive therapy protocol and receives royalties from books on it, and T. D. Borkovec, a co-author, wrote the cognitive behavioral protocol and receives royalties from his publications on it[2]. A Swedish pilot in primary care randomized 64 patients to metacognitive or intolerance-of-uncertainty therapy and found a large difference in worry favoring metacognitive therapy, but therapist adherence was rated weak to moderate[11].

Trials in depression and obsessive-compulsive disorder

In a Danish trial co-authored by Wells, 174 adults with major depression received up to 24 sessions of metacognitive therapy or cognitive behavioral therapy. Clinician-rated depression did not differ, but self-reported depression favored metacognitive therapy, with recovery rates of 74% and 52% after treatment. The authors noted that one of only two therapists treated 69% of patients and that allegiance effects were possible, since the trial ran in a cognitive behavioral clinic and its chief investigator originated the therapy[3]. A German trial, also with Wells as an author, gave 122 severely depressed outpatients six months of metacognitive therapy or behavioral activation. Neither treatment was superior at 12 months; response and remission were about 13% and 10% in both groups, and fewer patients deteriorated with metacognitive therapy[4].

In obsessive-compulsive disorder, 74 outpatients received 12 weekly sessions of metacognitive therapy or exposure and response prevention. Metacognitive therapy met the noninferiority criterion after treatment but not at six months[12]. A published critique argued that the trial had problems of transparency and of noninferiority testing, and that whether the therapy is noninferior to exposure remains undecided[13].

Meta-analyses and developer involvement

A 2018 meta-analysis of 25 studies, 15 of them randomized, found a large effect against waiting lists (g = 2.06) and pooled effects of 0.69 after treatment and 0.37 at follow-up against cognitive and behavioral interventions, while calling for more and larger trials[5]. A 2026 review of trials in depression reported a between-group effect of g = −1.28, with interpretation limited by small samples and few active comparisons[6].

Wells is an author of the Norwegian, Danish and German trials and of the attention training review[2][3][4][10]. The Dutch, Swedish and obsessive-compulsive disorder trials, and the detached mindfulness meta-analysis, list other authors[1][11][12][8].

Sources13

Numbered in order of first citation.

  1. 1.van der Heiden, C., Muris, P., & van der Molen, H. T. (2012). Randomized controlled trial on the effectiveness of metacognitive therapy and intolerance-of-uncertainty therapy for generalized anxiety disorder. Behaviour Research and Therapy, 50(2), 100–109. https://doi.org/10.1016/j.brat.2011.12.005
  2. 2.Nordahl, H. M., Borkovec, T. D., Hagen, R., Kennair, L. E. O., Hjemdal, O., Solem, S., Hansen, B., Haseth, S., & Wells, A. (2018). Metacognitive therapy versus cognitive–behavioural therapy in adults with generalised anxiety disorder. BJPsych Open, 4(5), 393–400. https://doi.org/10.1192/bjo.2018.54
  3. 3.Callesen, P., Reeves, D., Heal, C., & Wells, A. (2020). Metacognitive therapy versus cognitive behaviour therapy in adults with major depression: A parallel single-blind randomised trial. Scientific Reports, 10(1), 7878. https://doi.org/10.1038/s41598-020-64577-1
  4. 4.Schaich, A., Outzen, J., Assmann, N., Gebauer, C., Jauch-Chara, K., Alvarez-Fischer, D., Hüppe, M., Wells, A., Schweiger, U., Klein, J. P., & Fassbinder, E. (2023). The effectiveness of metacognitive therapy compared to behavioral activation for severely depressed outpatients: A single-center randomized trial. Psychotherapy and Psychosomatics, 92(1), 38–48. https://doi.org/10.1159/000527482
  5. 5.Normann, N., & Morina, N. (2018). The efficacy of metacognitive therapy: A systematic review and meta-analysis. Frontiers in Psychology, 9, 2211. https://doi.org/10.3389/fpsyg.2018.02211
  6. 6.Torabi, Z., Nikfarjam, M., & Dorcheh, A. K. (2026). The effect of metacognitive therapy on depressive symptoms from a transdiagnostic perspective: a systematic review, meta-regression and meta-analysis. Annals of General Psychiatry, 25(1), 62. https://doi.org/10.1186/s12991-026-00658-1
  7. 7.Wells, A. (2019). Breaking the cybernetic code: Understanding and treating the human metacognitive control system to enhance mental health. Frontiers in Psychology, 10, 2621. https://doi.org/10.3389/fpsyg.2019.02621
  8. 8.Myers, S. G., & Solem, S. (2026). Detached mindfulness as a stand-alone intervention: A systematic review and meta-analysis. Frontiers in Psychiatry, 17, 1771705. https://doi.org/10.3389/fpsyt.2026.1771705
  9. 9.Wells, A. (2009). Metacognitive therapy for anxiety and depression. Guilford Press.
  10. 10.Knowles, M. M., Foden, P., El-Deredy, W., & Wells, A. (2016). A systematic review of efficacy of the Attention Training Technique in clinical and nonclinical samples. Journal of Clinical Psychology, 72(10), 999–1025. https://doi.org/10.1002/jclp.22312
  11. 11.Af Winklerfelt Hammarberg, S., Toth-Pal, E., Jansson-Fröjmark, M., Lundgren, T., Westman, J., & Bohman, B. (2023). Intolerance-of-uncertainty therapy versus metacognitive therapy for generalized anxiety disorder in primary health care: A randomized controlled pilot trial. PLOS ONE, 18(6), e0287171. https://doi.org/10.1371/journal.pone.0287171
  12. 12.Exner, C., Kleiman, A., Haberkamp, A., Hansmeier, J., Milde, C., & Glombiewski, J. A. (2024). Metacognitive therapy versus exposure and response prevention for obsessive-compulsive disorder – A non-inferiority randomized controlled trial. Journal of Anxiety Disorders, 104, 102873. https://doi.org/10.1016/j.janxdis.2024.102873
  13. 13.Leichsenring, F., Heim, N., & Steinert, C. (2025). Is metacognitive therapy really non-inferior to exposure with response prevention in obsessive-compulsive disorder? – Methodological issues of non-inferiority testing. Journal of Anxiety Disorders, 110, 102980. https://doi.org/10.1016/j.janxdis.2025.102980

Further reading

  • Wells, A. (2009). Metacognitive therapy for anxiety and depression. Guilford Press.
  • Wells, A. (2019). Breaking the cybernetic code: Understanding and treating the human metacognitive control system to enhance mental health. Frontiers in Psychology, 10, 2621. https://doi.org/10.3389/fpsyg.2019.02621
  • Normann, N., & Morina, N. (2018). The efficacy of metacognitive therapy: A systematic review and meta-analysis. Frontiers in Psychology, 9, 2211. https://doi.org/10.3389/fpsyg.2018.02211

Cite this entry

  • APA 7

    Psych Dictionary. (2026, October 19). Metacognitive therapy (MCT). In Psych Dictionary. https://www.psychdictionary.com/therapies/metacognitive-therapy

  • MLA 9

    “Metacognitive Therapy (MCT).” Psych Dictionary, 19 Oct. 2026, www.psychdictionary.com/therapies/metacognitive-therapy.

Written by Editorial team. First published October 19, 2026. Editorial standards

Educational reference material. Nothing on this site is a diagnosis, a treatment recommendation or a substitute for care from a qualified clinician.